MMED
MiniMed
October 14, 2026 · intraday
- Rarity
- 1.63
- Peak move
- −9.35%
- Float cap
- $515M
MiniMed is a medical technology company spun out of Medtronic's diabetes business that develops, manufactures, and markets insulin delivery and diabetes management products, including insulin pumps, continuous glucose monitoring sensors, and related software. It sells these devices to people with diabetes, along with the healthcare providers, clinics, and payers who support them, across roughly 80 countries.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.